nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A monoclonal antibody targeted against epidermal growth factor receptor variant III enhances cisplatin efficiency
|
Li, Na |
|
2011 |
137 |
10 |
p. 1455-1461 |
artikel |
2 |
An immune function assay predicts post-transplant recurrence in patients with hepatocellular carcinoma
|
Cheng, Jian-Wen |
|
2011 |
137 |
10 |
p. 1445-1453 |
artikel |
3 |
Augmentation of T-cell immune responses and signal transduction proteins in oral cancer patients: potential for IL-2-mediated immunotherapy
|
Cheriyan, Vino T. |
|
2011 |
137 |
10 |
p. 1435-1444 |
artikel |
4 |
Cancer-derived matrix metalloproteinase-9 contributes to tumor tolerance
|
Wang, Bin-Quan |
|
2011 |
137 |
10 |
p. 1525-1533 |
artikel |
5 |
Cell death-inducing effect of novel palladium(II) and platinum(II) complexes on non-small cell lung cancer cells in vitro
|
Ulukaya, Engin |
|
2011 |
137 |
10 |
p. 1425-1434 |
artikel |
6 |
Correlation between the expression of the BAG-1 gene and clinicopathologic factors in colorectal cancer
|
Sun, Nian-Feng |
|
2011 |
137 |
10 |
p. 1419-1424 |
artikel |
7 |
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: 7-year follow-up of a rare clinicopathologic syndrome
|
Falkenstern-Ge, R. F. |
|
2011 |
137 |
10 |
p. 1495-1498 |
artikel |
8 |
Down-regulation of TWIST decreases migration and invasion of laryngeal carcinoma Hep-2 cells by regulating the E-cadherin, N-cadherin expression
|
Yu, Liang |
|
2011 |
137 |
10 |
p. 1487-1493 |
artikel |
9 |
Efficacy and safety of CHG regimen (low-dose cytarabine, homoharringtonine with G-CSF priming) as induction chemotherapy for elderly patients with high-risk MDS or AML transformed from MDS
|
Wu, Lingyun |
|
2011 |
137 |
10 |
p. 1563-1569 |
artikel |
10 |
Genome-wide identification of possible methylation markers chemosensitive to targeted regimens in colorectal cancers
|
Kim, Jin C. |
|
2011 |
137 |
10 |
p. 1571-1580 |
artikel |
11 |
GPx-1 polymorphism (rs1050450) contributes to tumor susceptibility: evidence from meta-analysis
|
Chen, Jiawei |
|
2011 |
137 |
10 |
p. 1553-1561 |
artikel |
12 |
Interstitial lung disease associated with gemcitabine treatment in patients with non-small-cell lung cancer and pancreatic cancer
|
Umemura, Shigeki |
|
2011 |
137 |
10 |
p. 1469-1475 |
artikel |
13 |
Introduction of pro-interleukin-16 inhibits T-lymphoblastic leukemia growth in mice
|
Richmond, Jillian |
|
2011 |
137 |
10 |
p. 1581-1585 |
artikel |
14 |
Lack of association between BARD1 Cys557Ser variant and breast cancer risk: a meta-analysis of 11,870 cases and 7,687 controls
|
Ding, Da-Peng |
|
2011 |
137 |
10 |
p. 1463-1468 |
artikel |
15 |
Molecular mechanisms of A3 adenosine receptor-induced G1 cell cycle arrest and apoptosis in androgen-dependent and independent prostate cancer cell lines: involvement of intrinsic pathway
|
Aghaei, Mahmoud |
|
2011 |
137 |
10 |
p. 1511-1523 |
artikel |
16 |
Response and prognosis of taxanes and anthracyclines neoadjuvant chemotherapy in patients with triple-negative breast cancer
|
Wu, Jiannan |
|
2011 |
137 |
10 |
p. 1505-1510 |
artikel |
17 |
Second-line chemotherapy with paclitaxel and doxifluridine after failure of S-1 in elderly patients with unresectable advanced or recurrent gastric cancer
|
Yakabe, Tomomi |
|
2011 |
137 |
10 |
p. 1499-1504 |
artikel |
18 |
Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulation
|
Baran, Yusuf |
|
2011 |
137 |
10 |
p. 1535-1544 |
artikel |
19 |
The CDK inhibitors in cancer research and therapy
|
Cicenas, Jonas |
|
2011 |
137 |
10 |
p. 1409-1418 |
artikel |
20 |
The hOGG1 gene 5′-UTR variant c.−53G>C contributes to the risk of gastric cancer but not colorectal cancer in the Chinese population
|
Liu, Xiufang |
|
2011 |
137 |
10 |
p. 1477-1485 |
artikel |
21 |
Zoledronic acid combined with chemotherapy bring survival benefits to patients with bone metastases from nasopharyngeal carcinoma
|
Jin, Ying |
|
2011 |
137 |
10 |
p. 1545-1551 |
artikel |